Prolonged life-threatening anaphylaxis to Floseal during partial nephrectomy: A case report

George McClintock , David Frishling , Yen Lam , Pascal Mancuso

Current Urology ›› 2025, Vol. 19 ›› Issue (3) : 198 -200.

PDF (163KB)
Current Urology ›› 2025, Vol. 19 ›› Issue (3) :198 -200. DOI: 10.1097/CU9.0000000000000200
Special Topic
research-article
Prolonged life-threatening anaphylaxis to Floseal during partial nephrectomy: A case report
Author information +
History +
PDF (163KB)

Abstract

Floseal Hemostatic Matrix is a topical hemostatic agent used across specialties and commonly applied to the renal bed during partial nephrectomy. Here we present the first adult case of Floseal allergy in the literature. A 62-year-old man underwent partial nephrectomy for a Bosniak type IV cyst. After unclamping the kidney, the patient declined precipitously, later determined due to an anaphylactic reaction to the Floseal placed on the renal bed. The patient had a prolonged anaphylactic reaction that required ionotropic support for over 24 h, possibly due to continued exposure. His tryptase level was elevated, and allergy testing revealed an allergy to the gelatin matrix component of the Floseal. Floseal anaphylaxis should be considered during episodes of cardiovascular collapse after drug administration. However, consideration should be given to removing it to prevent continued exposure and weighed against the risk of prolonged surgery in an anaphylactic patient.

Keywords

Allergy / Anaphylaxis / Floseal / Gelatin / Partial nephrectomy

Cite this article

Download citation ▾
George McClintock, David Frishling, Yen Lam, Pascal Mancuso. Prolonged life-threatening anaphylaxis to Floseal during partial nephrectomy: A case report. Current Urology, 2025, 19(3): 198-200 DOI:10.1097/CU9.0000000000000200

登录浏览全文

4963

注册一个新账户 忘记密码

Acknowledgments

None.

Statement of ethics

As the patient directly consented for the publication of this case, this work is exempt from a Human Research Ethics Committee review at our institution. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflicts of interest statement

The authors declare no conflicts of interest in relation to this work.

Funding source

No funding was obtained for this work.

Author contributions

GM, PM: Study concept and design;

GM: Data acquisition, drafting of manuscript;

GM, DF, YL, PM: Critical revision of the manuscript.

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1]

Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: The 2019 update. Eur Urol 2019; 75(5):799-810.

[2]

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: Efficacy and recommendations for use. Ann Surg 2010; 251(2):217-228.

[3]

Lang H, Mouracade P, Gimel P, et al. National prospective study on the use of local haemostatic agents during partial nephrectomy. BJU Int 2014; 113(5b):E56-E61.

[4]

Echave M, Oyagüez I, Casado MA. Use of Floseal® a human gelatine-thrombin matrix sealant, in surgery: A systematic review. BMC Surg 2014;14:111.

[5]

Volcheck GW, Hepner DL. Identification and management of perioperative anaphylaxis. J Allergy Clin Immunol Pract 2019; 7(7):2134-2142.

[6]

Levy JH, Castells MC. Perioperative anaphylaxis and the United States perspective. Anesth Analg 2011; 113(5):979-981.

[7]

Gibbs NM, Sadleir PH, Clarke RC, Platt PR. Survival from perioperative anaphylaxis in Western Australia 2000-2009. Br J Anaesth 2013; 111(4):589-593.

[8]

Harper NJN, Cook TM, Garcez T, et al. Anaesthesia, surgery, and life-threatening allergic reactions: Epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth 2018; 121(1):159-171.

[9]

Jiang Y, Yuan IH, Dutille EK, Bailey R, Shaker MS. Preventing iatrogenic gelatin anaphylaxis. Ann Allergy Asthma Immunol 2019; 123(4):366-374.

[10]

Lied GA, Lund KB, Storaas T. Intraoperative anaphylaxis to gelatin-based hemostatic agents: A case report. J Asthma Allergy 2019;12:163-167.

[11]

Burrow GH, Vincent KA, Krajbich JI, Aiona MD. Latex allergy in non-spina bifida patients: Unfamiliar intra-operative anaphylaxis. Aust N Z J Surg 1998; 68(3):183-185.

[12]

Oya S, Nakamori T, Kinoshita H. Incidence and characteristics of biphasic and protracted anaphylaxis: Evaluation of 114 inpatients. Acute Med Surg 2014; 1(4):228-233.

[13]

Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78(1 Pt1):76-83.

[14]

Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003; 97(5):1381-1395.

[15]

Muraro A, Roberts G, Worm M, et al. Anaphylaxis: Guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69(8):1026-1045.

PDF (163KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/